Exchange Traded Concepts, LLC Bausch Health Companies Inc. Transaction History

Exchange Traded Concepts, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$7.06 - $23.63 $3,332 - $11,153	472 New	472 $4,000
Q2 2021 Jul 30, 2021	SELL	$27.43 - $32.7 $11,081 - $13,210	-404 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$21.37 - $34.38 $20,386 - $32,798	-954 Reduced 70.25%	404 $13,000
Q4 2020 Jan 19, 2021	BUY	$15.31 - $21.12 $15,845 - $21,859	1,035 Added 320.43%	1,358 $28,000
Q3 2020 Oct 30, 2020	BUY	$14.88 - $20.13 $4,806 - $6,501	323 New	323 $5,000
Q2 2020 Jul 15, 2020	SELL	$13.31 - $20.51 $1,690 - $2,604	-127 Closed	0 $0
Q1 2020 Apr 14, 2020	SELL	$12.98 - $30.25 $272 - $635	-21 Reduced 14.19%	127 $2,000
Q4 2019 Jan 22, 2020	BUY	$18.89 - $31.89 $2,795 - $4,719	148 New	148 $4,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.77B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.